Cell Line : LC-1-SQ-SF
Cellosaurus Index : CVCL_5480
Cellosaurus ID : LC-1-SQ-SF
CCLE Name
: LC1SQSF_LUNG
CTRP1 Name
, CTRP2 Name
: LC1SQSF
Cancer Type : lung
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| LC-1-SQ-SF | (-)-gallocatechin-3-monogallate | CTRP1 | 0.2890 | 37.0000 |
|
| LC-1-SQ-SF | 16-beta-bromoandrosterone | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LC-1-SQ-SF | 16,16-dimethylprostaglandin-E2 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 17.0000 |
|
| LC-1-SQ-SF | 2-bromopyruvate | CTRP1 | 0.2603 | 37.0000 |
|
| LC-1-SQ-SF | 2-deoxyglucose | CTRP1 | 0.2890 | 37.0080 |
|
| LC-1-SQ-SF | 2-fluoropalmitic acid | CTRP1 | 0.2890 | 37.0000 |
|
| LC-1-SQ-SF | 2,4-dideoxy-DC-45-A2 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | 3-chloro-L-alanine | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | 3-Cl-AHPC | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | 4-methylfasudil | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | 5-benzyl-9-tert-butyl-paullone | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | 6-diazo-5-oxo-L-norleucine | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | 6-NBDG | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | 7-nitroindazole | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | A-804598 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | AA-COCF3 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LC-1-SQ-SF | ABH | CTRP1 | 0.2890 | 37.0000 |
|
| LC-1-SQ-SF | ABT-751 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | ABT737 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LC-1-SQ-SF | AC55649 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LC-1-SQ-SF | AEW541 | CCLE | 0.0025 | 8.0000 |
|
| LC-1-SQ-SF | Afatinib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | AGK-2 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LC-1-SQ-SF | Alda-1 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | Alisertib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LC-1-SQ-SF | Alpelisib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | alpha-cyano-4-hydroxycinnamic acid | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | alvocidib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | AM-580 | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| LC-1-SQ-SF | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | ASN 05257430 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LC-1-SQ-SF | aspirin | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | AT-406 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | AT13387 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | AT7867 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | austocystin D | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LC-1-SQ-SF | avicin D | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | avrainvillamide | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LC-1-SQ-SF | Axitinib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | AZ-3146 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | azacitidine | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | AZD-7545 | CTRP2,CTRP1 | 0.0023 | 74.0000 |
|
| LC-1-SQ-SF | AZD1480 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | AZD4547 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | AZD6482 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | AZD7762 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | AZD8055 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | B02 | CTRP2 | 0.0041 | 130.0000 |
|
| LC-1-SQ-SF | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | batimastat | CTRP1 | 0.2890 | 37.0000 |
|
| LC-1-SQ-SF | Bax channel blocker | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LC-1-SQ-SF | BCL-LZH-4 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BEC | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | Belinostat | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | bendamustine | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Bexarotene | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BI-2536 | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | BIBR-1532 | CTRP2 | 0.0081 | 270.0000 |
|
| LC-1-SQ-SF | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | bistramide A | CTRP1 | 0.2517 | 32.2330 |
|
| LC-1-SQ-SF | BIX-01294 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LC-1-SQ-SF | BIX-01338 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | blebbistatin | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BMS-191011 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | BMS-195614 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BMS-345541 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BMS-536924 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LC-1-SQ-SF | BMS-641988 | CTRP1 | 0.2890 | 37.0000 |
|
| LC-1-SQ-SF | BMS-754807 | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | Bortezomib | CTRP2,CTRP1 | 0.0000 | 33.3330 |
|
| LC-1-SQ-SF | Bosutinib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | bovinocidin | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | BRD-A02303741 | CTRP2 | 0.0017 | 55.0000 |
|
| LC-1-SQ-SF | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LC-1-SQ-SF | BRD-A05715709 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | BRD-A86708339 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K02251932 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K02492147 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K03536150 | CTRP2 | 0.0081 | 270.0000 |
|
| LC-1-SQ-SF | BRD-K04800985 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K09587429 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K11533227 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K13999467 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K16147474 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K17060750 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K24690302 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| LC-1-SQ-SF | BRD-K28456706 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K29313308 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K33199242 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K34222889 | CTRP2 | 0.0017 | 57.0000 |
|
| LC-1-SQ-SF | BRD-K35604418 | CTRP2 | 0.0081 | 270.0000 |
|
| LC-1-SQ-SF | BRD-K37390332 | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | BRD-K41597374 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K42260513 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K48477130 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K50799972 | CTRP2 | 0.0020 | 33.0000 |
|
| LC-1-SQ-SF | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K51831558 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K52037352 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K55116708 | CTRP2 | 0.0020 | 33.0000 |
|
| LC-1-SQ-SF | BRD-K55473186 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K61166597 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K63431240 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | BRD-K66453893 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K70511574 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K71781559 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K71935468 | CTRP2 | 0.0025 | 83.0000 |
|
| LC-1-SQ-SF | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K90370028 | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | BRD-K92856060 | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | BRD-K94991378 | CTRP2 | 0.0025 | 83.0000 |
|
| LC-1-SQ-SF | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-K99006945 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD-M00053801 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD1812 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD1835 | CTRP2 | 0.0041 | 130.0000 |
|
| LC-1-SQ-SF | BRD2649 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | BRD4132 | CTRP2 | 0.0049 | 80.0000 |
|
| LC-1-SQ-SF | BRD55319 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LC-1-SQ-SF | BRD6340 | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | BRD63610 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | BRD6368 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | BRD6430 | CTRP2 | 0.0010 | 17.0000 |
|
| LC-1-SQ-SF | BRD7137 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | BRD8899 | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | BRD8958 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | BRD9647 | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | BRD9786 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | BRD9876 | CTRP2 | 0.0041 | 130.0000 |
|
| LC-1-SQ-SF | brefeldin A | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LC-1-SQ-SF | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Cabozantinib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | canertinib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | capsaicin | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | Carboplatin | CTRP2 | 0.0041 | 66.0000 |
|
| LC-1-SQ-SF | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 47.0000 |
|
| LC-1-SQ-SF | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LC-1-SQ-SF | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | CAY10594 | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | CBB-1007 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | CCT036477 | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | CD-1530 | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| LC-1-SQ-SF | CD-437 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LC-1-SQ-SF | Cediranib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | cerulenin | CTRP2,CTRP1 | 0.0045 | 150.0000 |
|
| LC-1-SQ-SF | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | CHEMBL1222381 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| LC-1-SQ-SF | CHEMBL374350 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LC-1-SQ-SF | CHEMBL399379 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | CHIR-99021 | CTRP2 | 0.0024 | 80.0000 |
|
| LC-1-SQ-SF | chlorambucil | CTRP2 | 0.0081 | 270.0000 |
|
| LC-1-SQ-SF | CHM-1 | CTRP2 | 0.0005 | 16.0000 |
|
| LC-1-SQ-SF | CI-976 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| LC-1-SQ-SF | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | ciclosporin | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LC-1-SQ-SF | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | COL-3 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Compound 10b | CTRP1 | 0.2890 | 37.0000 |
|
| LC-1-SQ-SF | Compound 110 | CTRP1 | 0.2890 | 37.0000 |
|
| LC-1-SQ-SF | Compound 12 | CTRP1 | 0.2890 | 37.0000 |
|
| LC-1-SQ-SF | Compound 1541A | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LC-1-SQ-SF | compound 1B | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Compound 2 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | Compound 23 citrate | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LC-1-SQ-SF | Compound 4 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | Compound 44 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | Compound 7d-cis | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LC-1-SQ-SF | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | Crizotinib | CTRP2,CCLE | 0.0020 | 33.0000 |
|
| LC-1-SQ-SF | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LC-1-SQ-SF | cucurbitacin I | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | curcumin | CTRP2 | 0.0051 | 170.0000 |
|
| LC-1-SQ-SF | cyanoquinoline 11 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | cytochalasin B | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LC-1-SQ-SF | cytosporone B | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | Dabrafenib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Dacarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Dactolisib | CTRP2 | 0.0005 | 17.0000 |
|
| LC-1-SQ-SF | dalcetrapib | CTRP1 | 0.2587 | 33.1000 |
|
| LC-1-SQ-SF | Daporinad | CTRP2 | 0.0001 | 2.0000 |
|
| LC-1-SQ-SF | Dasatinib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | DC-45-A2 | CTRP1 | 0.2890 | 37.0000 |
|
| LC-1-SQ-SF | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LC-1-SQ-SF | dexamethasone | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LC-1-SQ-SF | DG-041 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | dichloroacetic acid | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | Dinaciclib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | DL-TBOA | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | Docetaxel | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LC-1-SQ-SF | Doxorubicin | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LC-1-SQ-SF | eflornithine | CTRP1 | 0.2890 | 37.0000 |
|
| LC-1-SQ-SF | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Entinostat | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | epigallocatechin-3-monogallate | CTRP2 | 0.0090 | 300.0000 |
|
| LC-1-SQ-SF | erastin | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Erlotinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | erlotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LC-1-SQ-SF | ethylidene glucose | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | etomoxir | CTRP2,CTRP1 | 0.0090 | 300.0000 |
|
| LC-1-SQ-SF | Etoposide | CTRP2 | 0.0009 | 28.0000 |
|
| LC-1-SQ-SF | ETP-46464 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | fatostatin | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | Fedratinib | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LC-1-SQ-SF | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | fluoropyruvate | CTRP1 | 0.2890 | 37.0000 |
|
| LC-1-SQ-SF | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| LC-1-SQ-SF | fluvastatin | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | FMK-PA | CTRP1 | 0.2890 | 37.0000 |
|
| LC-1-SQ-SF | Foretinib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | fosfomycin | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | FQI-2 | CTRP2 | 0.0010 | 2.1000 |
|
| LC-1-SQ-SF | fumagillol | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 |
|
| LC-1-SQ-SF | GANT-61 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | GDC-0879 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Gefitinib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Gemcitabine | CTRP2,CTRP1 | 0.0010 | 37.0000 |
|
| LC-1-SQ-SF | glibenclamide | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | Gly-Gly-PALO | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | GMX-1778 | CTRP2,CTRP1 | 0.0000 | 33.3330 |
|
| LC-1-SQ-SF | gossypol | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LC-1-SQ-SF | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | GSK1059615 | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | GSK2636771 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | GSK461364 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | GW-405833 | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| LC-1-SQ-SF | GW843682X | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | HBX-41108 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | HC-067047 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | HLI 373 | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | hyperforin | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | I-BET-762 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | I-BET151 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Ibrutinib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | IC-87114 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | idarubicin | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | Idelalisib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Imatinib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | importazole | CTRP2 | 0.0061 | 200.0000 |
|
| LC-1-SQ-SF | indisulam | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LC-1-SQ-SF | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | iso-DC-45-A2 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | isoevodiamine | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | isonicotinohydroxamic acid | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | ISOX:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| LC-1-SQ-SF | istradefylline | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | itraconazole | CTRP2,CTRP1 | 0.0005 | 33.3330 |
|
| LC-1-SQ-SF | IU1 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | JQ-1:MK-0752 (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LC-1-SQ-SF | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LC-1-SQ-SF | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LC-1-SQ-SF | JQ1 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | JW-480 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | JW-74 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | JZL-184 | CTRP1 | 0.2890 | 37.0000 |
|
| LC-1-SQ-SF | KH-CB19 | CTRP2 | 0.0005 | 17.0000 |
|
| LC-1-SQ-SF | KHS101 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Ki8751 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | kinetin riboside | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | Ko-143 | CTRP2 | 0.0041 | 130.0000 |
|
| LC-1-SQ-SF | KPT185 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | KU 0060648 | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | KU-55933 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | KU-60019 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | L-685458 | CTRP2,CTRP1,CCLE | 0.0025 | 37.0000 |
|
| LC-1-SQ-SF | Lapatinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | LBH-589 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | LBW242 | CCLE | 0.0025 | 8.0000 |
|
| LC-1-SQ-SF | LE-135 | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Lenalidomide | CTRP1 | 0.2890 | 37.0000 |
|
| LC-1-SQ-SF | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | leucascandrolide A | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | Linifanib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Linsitinib | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | lonidamine | CTRP1 | 0.2890 | 37.0000 |
|
| LC-1-SQ-SF | losartan | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | lovastatin acid | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| LC-1-SQ-SF | LRRK2-IN-1 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | LY-2183240 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LC-1-SQ-SF | LY-2365109 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | m-3M3-FBS | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | manumycin A | CTRP2 | 0.0009 | 30.0000 |
|
| LC-1-SQ-SF | maraviroc | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | marinopyrrole A | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Masitinib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Merck60 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LC-1-SQ-SF | Methotrexate | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | methylstat | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | MG-132 | CTRP2 | 0.0006 | 20.0000 |
|
| LC-1-SQ-SF | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | MI-1 | CTRP2 | 0.0020 | 33.0000 |
|
| LC-1-SQ-SF | MI-2 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | MIRA-1 | CTRP2 | 0.0020 | 17.0000 |
|
| LC-1-SQ-SF | mitomycin | CTRP2 | 0.0015 | 50.0000 |
|
| LC-1-SQ-SF | MK-0752 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | MK-1775 | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | MK-2206 | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | MK-591 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | ML006 | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| LC-1-SQ-SF | ML007 | CTRP1 | 0.2890 | 37.0000 |
|
| LC-1-SQ-SF | ML013 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | ML030 | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | ML037 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | ML038 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | ML039 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | ML050 | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | ML101 | CTRP1 | 0.2890 | 37.0000 |
|
| LC-1-SQ-SF | ML162 | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | ML203 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LC-1-SQ-SF | ML210 | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | ML258 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| LC-1-SQ-SF | ML320 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | ML334 diastereomer | CTRP2 | 0.0041 | 130.0000 |
|
| LC-1-SQ-SF | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | MLN2480 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | momelotinib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | myricetin | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | N-oxalyl-D-phenylalanine | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | N5-iminoethyl-L-ornithine | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | N9-isopropylolomoucine | CTRP2 | 0.0120 | 400.0000 |
|
| LC-1-SQ-SF | nakiterpiosin | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LC-1-SQ-SF | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | Navitoclax | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LC-1-SQ-SF | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | navitoclax:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LC-1-SQ-SF | necrostatin-1 | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| LC-1-SQ-SF | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | necrosulfonamide | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Nelarabine | CTRP2 | 0.0020 | 33.0000 |
|
| LC-1-SQ-SF | neopeltolide | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | neratinib | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | nifedipine | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | Nilotinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | nintedanib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | NPC-26 | CTRP2 | 0.0012 | 40.0000 |
|
| LC-1-SQ-SF | NSC 74859 | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| LC-1-SQ-SF | NSC23766 | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| LC-1-SQ-SF | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | NSC48300 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | NSC632839 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LC-1-SQ-SF | NSC95397 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LC-1-SQ-SF | Nutlin-3a | CTRP2,CTRP1,CCLE | 0.0025 | 150.0000 |
|
| LC-1-SQ-SF | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | NVP-ADW742 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | NVP-TAE684 | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | O-6-benzylguanine | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Obatoclax Mesylate | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Olaparib | CTRP2,CTRP1 | 0.0045 | 150.0000 |
|
| LC-1-SQ-SF | oligomycin A | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LC-1-SQ-SF | omacetaxine mepesuccinate | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | OSI-027 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | OSI-930 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | OSW-1 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| LC-1-SQ-SF | Oxaliplatin | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | oxythiamine | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | PAC-1 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LC-1-SQ-SF | Paclitaxel | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Palbociclib | CCLE | 0.0025 | 8.0000 |
|
| LC-1-SQ-SF | palmostatin B | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | pandacostat | CTRP2,CTRP1 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | panduratin A | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | Panobinostat | CCLE | 0.0025 | 8.0000 |
|
| LC-1-SQ-SF | parbendazole | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Parthenolide | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Pazopanib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | PD 153035 | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | PD0325901 | CCLE | 0.0025 | 8.0000 |
|
| LC-1-SQ-SF | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | PDMP | CTRP2 | 0.0065 | 210.0000 |
|
| LC-1-SQ-SF | Pemetrexed | CTRP1 | 0.2890 | 37.0000 |
|
| LC-1-SQ-SF | Pevonedistat | CTRP2,CTRP1 | 0.0180 | 37.0000 |
|
| LC-1-SQ-SF | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | PF-3758309 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | PF-3845 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | PF-4800567 hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | PF-750 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| LC-1-SQ-SF | PHA-665752 | CCLE | 0.0025 | 8.0000 |
|
| LC-1-SQ-SF | PHA-793887 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | phloretin | CTRP2,CTRP1 | 0.0180 | 590.0000 |
|
| LC-1-SQ-SF | PI-103 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LC-1-SQ-SF | Pictilisib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | pifithrin-alpha | CTRP2 | 0.0071 | 230.0000 |
|
| LC-1-SQ-SF | pifithrin-mu | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LC-1-SQ-SF | PIK-75 | CTRP1 | 0.2890 | 37.0000 |
|
| LC-1-SQ-SF | PIK-93 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Piperlongumine | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LC-1-SQ-SF | piperlongumine:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | pitstop2 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | PL-DI | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | pluripotin | CTRP2,CTRP1 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | PLX-4032 | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | PLX-4720 | CTRP2,CCLE | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | PP-30 | CTRP1 | 0.2890 | 37.0000 |
|
| LC-1-SQ-SF | PRIMA-1 | CTRP2,CTRP1 | 0.0051 | 170.0000 |
|
| LC-1-SQ-SF | PRL-3 Inhibitor I | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| LC-1-SQ-SF | procarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | prochlorperazine | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | PT-630 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | purmorphamine | CTRP2,CTRP1 | 0.0046 | 150.0000 |
|
| LC-1-SQ-SF | PX-12 | CTRP2 | 0.0030 | 100.0000 |
|
| LC-1-SQ-SF | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | quinoclamine | CTRP1 | 0.2890 | 37.0000 |
|
| LC-1-SQ-SF | Quizartinib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | R428 | CTRP2 | 0.0020 | 33.0000 |
|
| LC-1-SQ-SF | racemic-2,4-dideoxy-DC-45-A2 | CTRP1 | 0.2890 | 37.0000 |
|
| LC-1-SQ-SF | RAF265 | CCLE | 0.0025 | 8.0000 |
|
| LC-1-SQ-SF | Rapamycin | CTRP2,CTRP1 | 0.0010 | 37.0000 |
|
| LC-1-SQ-SF | Regorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Repligen 136 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | RepSox | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | RG-108 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| LC-1-SQ-SF | rigosertib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | RITA | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LC-1-SQ-SF | Ro-28-1675 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | RO4929097 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | rosiglitazone | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | rotenone | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | Ruxolitinib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | salermide | CTRP2 | 0.0120 | 400.0000 |
|
| LC-1-SQ-SF | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0066 | 220.0000 |
|
| LC-1-SQ-SF | Saracatinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | SB-225002 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LC-1-SQ-SF | SB-431542 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | SCH-529074 | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | SCH-79797 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LC-1-SQ-SF | Selisistat | CTRP2 | 0.0024 | 80.0000 |
|
| LC-1-SQ-SF | Selumetinib | CTRP2,CCLE | 0.0025 | 270.0000 |
|
| LC-1-SQ-SF | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| LC-1-SQ-SF | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| LC-1-SQ-SF | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| LC-1-SQ-SF | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| LC-1-SQ-SF | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| LC-1-SQ-SF | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| LC-1-SQ-SF | selumetinib:piperlongumine (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| LC-1-SQ-SF | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| LC-1-SQ-SF | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 200.0000 |
|
| LC-1-SQ-SF | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| LC-1-SQ-SF | selumetinib:vorinostat (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| LC-1-SQ-SF | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Sepantronium bromide | CTRP2 | 0.0000 | 1.0000 |
|
| LC-1-SQ-SF | Serdemetan | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | SID 26681509 | CTRP2,CTRP1 | 0.0090 | 300.0000 |
|
| LC-1-SQ-SF | sildenafil | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| LC-1-SQ-SF | silmitasertib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | simvastatin | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LC-1-SQ-SF | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| LC-1-SQ-SF | SJ-172550 | CTRP2,CTRP1 | 0.0010 | 37.0000 |
|
| LC-1-SQ-SF | skepinone-L | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | SKI-II | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| LC-1-SQ-SF | SMER-3 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | SN-38 | CTRP2,CTRP1 | 0.0000 | 37.0000 |
|
| LC-1-SQ-SF | SNS-032 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | SNX-2112 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LC-1-SQ-SF | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| LC-1-SQ-SF | Sorafenib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | sotrastaurin | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | sparfosic acid | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | spautin-1 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Sphingosine Kinase 1 Inhibitor II | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | SR-II-138A | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LC-1-SQ-SF | SR1001 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | STF-31 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | SU11274 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Sunitinib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | SZ4TA2 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | T-5345967 | CTRP2,CTRP1 | 0.0160 | 270.0000 |
|
| LC-1-SQ-SF | tacedinaline | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | tacrolimus | CTRP2,CTRP1 | 0.0023 | 74.0000 |
|
| LC-1-SQ-SF | tamatinib | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | Tamoxifen | CTRP2 | 0.0030 | 100.0000 |
|
| LC-1-SQ-SF | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Tanespimycin | CTRP2,CTRP1,CCLE | 0.0010 | 37.0000 |
|
| LC-1-SQ-SF | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| LC-1-SQ-SF | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | Telomerase Inhibitor IX | CTRP2,CTRP1 | 0.0010 | 37.0000 |
|
| LC-1-SQ-SF | Temozolomide | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | TGX-115 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | TGX221 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Thalidomide | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | tipifarnib-P1 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LC-1-SQ-SF | tipifarnib-P2 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | tivantinib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Tivozanib | CTRP2 | 0.0004 | 13.0000 |
|
| LC-1-SQ-SF | TKI258 | CCLE | 0.0025 | 8.0000 |
|
| LC-1-SQ-SF | Topotecan | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | tosedostat | CTRP2 | 0.0081 | 270.0000 |
|
| LC-1-SQ-SF | Tozasertib | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | TPCA-1 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Trametinib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Tretinoin | CTRP2,CTRP1 | 0.0041 | 66.0000 |
|
| LC-1-SQ-SF | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| LC-1-SQ-SF | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0410 | 83.0000 |
|
| LC-1-SQ-SF | triacsin C | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | triptolide | CTRP2,CTRP1 | 0.0000 | 33.3330 |
|
| LC-1-SQ-SF | TW 37 | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | ubistatin B | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | UNC0321 | CTRP2 | 0.0020 | 33.0000 |
|
| LC-1-SQ-SF | UNC0638 | CTRP2 | 0.0010 | 17.0000 |
|
| LC-1-SQ-SF | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | VAF-347 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | valdecoxib | CTRP2,CTRP1 | 0.0180 | 600.0000 |
|
| LC-1-SQ-SF | vandetanib | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Veliparib | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | Venetoclax | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | VER-155008 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LC-1-SQ-SF | Vincristine | CTRP2 | 0.0041 | 130.0000 |
|
| LC-1-SQ-SF | Vismodegib | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | Vorinostat | CTRP2,CTRP1 | 0.0010 | 37.0000 |
|
| LC-1-SQ-SF | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | WT-161 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | WZ4002 | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | WZ8040 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | XAV939 | CTRP1 | 0.2890 | 37.0000 |
|
| LC-1-SQ-SF | XL765 | CTRP2 | 0.0020 | 66.0000 |
|
| LC-1-SQ-SF | YK-4-279 | CTRP2 | 0.0010 | 33.0000 |
|
| LC-1-SQ-SF | YL54 | CTRP2 | 0.0020 | 33.0000 |
|
| LC-1-SQ-SF | YM-022 | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | ZD-6474 | CCLE | 0.0025 | 8.0000 |
|
| LC-1-SQ-SF | zebularine | CTRP2,CTRP1 | 0.0180 | 590.0000 |
|
| LC-1-SQ-SF | zileuton | CTRP1 | 0.2603 | 33.3330 |
|
| LC-1-SQ-SF | ZSTK474 | CTRP2 | 0.0020 | 66.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC